companydata.dkNOVOZYMES BIOINDUSTRIAL CHINA A/S: Financial statements 2020
CVR: 21599042
NOVOZYMES BIOINDUSTRIAL CHINA A/S (CVR 21599042) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -31,924 and a net result of DKK 45,639,311 compared with DKK 283,492,654 the year before. Equity amounted to DKK 817,751,079. The solvency ratio was 100%.
- Gross Profit
- -31,924 kr.
- Profit/Loss
- 45,639,311 kr.
- Equity
- 817,751,079 kr.
- Total Assets
- 817,782,328 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -32 t. | 45.6 mio. | 817.8 mio. | 0 |
| 2019 | - | -38 t. | 283.5 mio. | 1.1 mia. | 0 |
| 2018 | - | -68 t. | -54 t. | 768.6 mio. | - |
| 2017 | - | -73 t. | -58 t. | 770.2 mio. | - |
| 2016 | - | -78 t. | -61 t. | 770.2 mio. | - |
How creditworthy is NOVOZYMES BIOINDUSTRIAL CHINA A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
NOVOZYMES BIOINDUSTRIAL CHINA A/S has published its annual report for 2019. Gross profit came to DKK -37,500, and the net result was DKK 283,492,654.
About NOVOZYMES BIOINDUSTRIAL CHINA A/S
NOVOZYMES BIOINDUSTRIAL CHINA A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 1999. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Lisbet Kragelund. The company is owned by NOVOZYMES A/S. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 119,380,365 compared with DKK 394,633,084 the year before. Equity amounted to DKK 1,018,536,331.